Dermatologic Clinical Trials

11 recruitingLast updated: May 8, 2026

There are 11 actively recruiting dermatologic clinical trials across 5 countries. Studies span Phase 1, Phase 4. Top locations include Toulouse, France, Lexington, Massachusetts, United States, Argenteuil, France. Updated daily from ClinicalTrials.gov.


Dermatologic Trials at a Glance

11 actively recruiting trials for dermatologic are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Phase 1 with 1 trial, with the heaviest enrollment activity in Toulouse, Lexington, and Argenteuil. Lead sponsors running dermatologic studies include Memorial Sloan Kettering Cancer Center, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and Joined Bio.

Browse dermatologic trials by phase

Treatments under study

About Dermatologic Clinical Trials

Looking for clinical trials for Dermatologic? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Dermatologic trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Dermatologic clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting

Direct to Patient Minimal Risk Biospecimen and Data Collection Research

HealthyKidney DiseaseLupus+3 more
Joined Bio100,000 enrolled1 locationNCT07128966
Recruiting

Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target

Dermatologic Diseases
University of California, Irvine85 enrolled2 locationsNCT00842283
Recruiting

Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases

Skin DiseasesAutoimmune Bullous DermatosisDysimmune Dermatological Diseases+1 more
University Hospital, Toulouse800 enrolled1 locationNCT06387654
Recruiting

Studies of Dermatologic Diseases Biospecimen Acquisition Protocol

Healthy VolunteersCarcinoma, Merkel CellDermatologic Conditions+1 more
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)700 enrolled1 locationNCT02471352
Recruiting
Phase 4

Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus

PemphigusDermatologic Disease
University Hospital, Rouen133 enrolled34 locationsNCT05898308
Recruiting

Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments

CancerDermatologic Conditions
Memorial Sloan Kettering Cancer Center1,025 enrolled4 locationsNCT02296450
Recruiting

A Skin Image Reference Tool to Aid Healthcare Providers' Diagnosis

Dermatologic Disease
Wake Forest University Health Sciences400 enrolled1 locationNCT07033169
Recruiting

Psorcast Mobile Study

Joint PainPsoriasisPsoriatic Arthritis+6 more
Sage Bionetworks1,000 enrolled1 locationNCT05621369
Recruiting

Addressing Inequity in Dermatology

Dermatologic Disease
University of Manchester200 enrolled1 locationNCT06056648
Recruiting

Collection and Distribution of Biospecimens for Novel Research Uses

CancerHealthyAutoimmune Diseases+5 more
iSpecimen Inc10,000 enrolled2 locationsNCT03848962
Recruiting
Phase 1

A randomised double blind placebo controlled trial to determine whether topical pre-treatment of injection sites can reduce the pain associated with needles

Pain reduction associated with needle insertion for venous puncture or dermatological procedures
QuikMed Holdings PTY LTD50 enrolled1 locationACTRN12612000205831